Strategies to Manage Antibody Drug Conjugates (ADC) - Related Toxicities in Breast Cancer - Episode 2
ADCs in Breast Cancer: Mechanism of Action, and Components
Medical experts discuss the distinct mechanisms and components of different antibody-drug conjugates (ADCs), including the drug, antibody, and linker, and how these components contribute to the mechanisms of ADC-related toxicities.
Video content above is prompted by the following:
- What are the different mechanisms between these antibody-drug conjugates (ADCs), as well as the different components that make up these ADCs (ie, drug, antibody, linker)?
- Please briefly comment on how the different ADC components relate to the mechanism of some of the ADC-related toxicities.
Related Content:
